We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 445

High investment interest in RNAi therapeutics

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 20 2014

With investments soaring in projects exploring therapeutic applications of RNA interference (RNAi), the field has apparently begun a significant

HHS Inspector General issues report on FDA employee computer monitoring

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 20 2014

The Inspector General (IG) of the U.S. Department of Human Health and services (HHs) has issued a report titled "Review of the Food and Drug

FY 2015 budget proposal underfunds life sciences research

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 20 2014

The Information Technology and Innovation Foundation (ITIF) notes that the Obama administration's fiscal year (FY) 2015 budget proposes a near

Top U.S. biopharma clusters identified

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 20 2014

Genetic Engineering & Biotechnology News has issued its list of top 10 U.S. biopharma clusters based on parameters such as patents applied for and

Hearing on OTC drug review scheduled

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 27 2014

The U.S. Food and Drug Administration (FDA) will conduct a public hearing on March 25-26, 2014, in silver spring, Maryland, "to obtain information

FDA launches secure supply chain pilot program

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 27 2014

The U.S. Food and Drug Administration (FDA) has announced that 13 pharmaceutical companies have qualified to participate in its two-year pilot

Life sciences investments slow in 2013 overall, show vigor in Q4

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 27 2014

According to PricewaterhouseCoopers (PwC) latest MoneyTree Report, venture capital funding for the life sciences sector, including biotechnology and

U.S. Supreme Court considers attorney’s fees in patent litigation

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 27 2014

The U.S. supreme Court has heard oral argument in two cases presenting issues relating to the standards that trial and appellate courts apply when

USPTO Deputy Director discusses executive actions to improve patent system

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 27 2014

U.S. Patent and Trademark Office (USPTO) Deputy Director Michelle Lee has reported the initiatives that the office has already undertaken or will

Divided Federal Circuit rules claim construction is de novo review matter

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 27 2014

A split en banc Federal Circuit Court of Appeals has declined an invitation to overturn 15-year-old precedent and determined that "appellate review